Pharmaceutical - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

151 to 175 of 7083 results

Takeda presents Phase III data for Entyvio in UC and Crohn’s Disease

Takeda presents Phase III data for Entyvio in UC and Crohn’s Disease

02-10-2014

Japan’s largest drugmaker Takeda Pharmaceutical today announced new data from a Phase III study of…

EntyvioGastro-intestinalsJapanPharmaceuticalResearchTakeda Pharma

Intarcia’s Phase III diabetes data shows sustained blood sugar control

Intarcia’s Phase III diabetes data shows sustained blood sugar control

02-10-2014

USA-based Intarcia Therapeutics has announced successful top-line results from two of its four Phase…

DiabetesExenatide InjectionIntarcia TherapeuticsPharmaceuticalResearchUSA

Ebola vaccines could be available early 2015, says WHO

Ebola vaccines could be available early 2015, says WHO

02-10-2014

The World Health Organization has issued an assessment of the situation regarding two candidate Ebola…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalPharmaceuticalResearch

NICE recommends Lundbeck’s Selincro for alcohol dependence

NICE recommends Lundbeck’s Selincro for alcohol dependence

02-10-2014

Today’s announcement that the UK’s National Institute for Health and Care Excellence (NICE) recommends…

Biotie TherapiesLundbeckNeurologicalPharmaceuticalPricingRegulationSelincroUK

Novartis returns rights to Enanta’s NS5A Inhibitor EDP-239 for hep C

01-10-2014

USA-based discovery and development company Enanta Pharmaceuticals says it has entered into an agreement…

Anti-viralsEnanta PharmaceuticalsLicensingNovartisPharmaceutical

Islet Sciences announces merger with Brighthaven Ventures

Islet Sciences announces merger with Brighthaven Ventures

01-10-2014

Metabolic biopharma specialist Islet Sciences has announced a merger with Brighthaven Ventures, a privately-held…

Islet SciencesMergers & AcquisitionsNephrology and HepatologyPharmaceuticalremogliflozinUSA

Erytech reports positive Phase III results from Graspa study in acute lymphoblastic leukemia

Erytech reports positive Phase III results from Graspa study in acute lymphoblastic leukemia

01-10-2014

French drugmaker Erytech and Italy's Recordati have reported positive Phase III results from its study…

Erytech PharmaGraspaOncologyPharmaceuticalRecordatiResearch

Legal change to reduce patent infringements could attract drug research back to the UK

Legal change to reduce patent infringements could attract drug research back to the UK

01-10-2014

A legal amendment which takes effect today could help to attract drug research back to the UK, according…

LegalPatentsPharmaceuticalUKUnited Kingdom

Health Canada issues import ban from three Indian drug plants

Health Canada issues import ban from three Indian drug plants

01-10-2014

Regulator Health Canada has taken action to stop the imports from three Indian manufacturing sites.

Apotex Research Private LimitedCanadaIndiaIpca LaboratoriesPharmaceuticalRegulation

EC guideline on facilitating applications for pediatric investigation plans

EC guideline on facilitating applications for pediatric investigation plans

01-10-2014

The European Commission has published a revised guideline on applications for pediatric investigation…

Clinical researchEuropeEuropean UnionPharmaceuticalResearch

FDA grants to stimulate drug and device development for rare diseases

FDA grants to stimulate drug and device development for rare diseases

01-10-2014

The US Food and Drug Administration yesterday announced it has awarded 15 grants totaling more than $19…

FinancialPharmaceuticalRare diseasesResearchUSA

Long-acting insulin is safer, more effective for patients with type 1 diabetes

Long-acting insulin is safer, more effective for patients with type 1 diabetes

01-10-2014

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with type…

CanadaDiabetesInsulin DetemirInsulin Glargine [rDNA origin] InjectionPharmaceuticalResearch

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

01-10-2014

German family-owned drug major Boehringer Ingelheim has presented new data at the annual congress of…

afatinibArray BioPharmabinimetinibBoehringer IngelheimGermanyOncologyPharmaceuticalResearch

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

01-10-2014

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid,…

EisaiHalavenJapanOncologyPharmaceuticalResearchSpain

Salix and Progenics receive FDA approval for Relistor injection for opioid-induced constipation

Salix and Progenics receive FDA approval for Relistor injection for opioid-induced constipation

01-10-2014

Gastrointestinal specialist Salix Pharmaceuticals and Progenix Pharmaceuticals have had their Relistor…

Gastro-intestinalsPharmaceuticalProgenics PharmaceuticalsRegulationRelistorSalix PharmaceuticalsUSA

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

01-10-2014

The annual congress of the European Society for Medical Oncology (ESMO) came to a close in Madrid, Spain,…

AstraZenecaAZD9291IressaOncologyPharmaceuticalResearchUK

FDA grants approval for Xtandi in metastatic prostate cancer

FDA grants approval for Xtandi in metastatic prostate cancer

01-10-2014

Japanese drug major Astellas Pharma and Medivation has received extended approval for Xtandi (enzalutamide)…

Astellas PharmaDiplomatMedivationOncologyPharmaceuticalRegulationUSAXtandi

Ritter appoints Michael Step as chief executive

Ritter appoints Michael Step as chief executive

01-10-2014

Privately-held gastrointestinal company Ritter Pharmaceuticals has appointed Michael Step as chief executive.

BoardroomGastro-intestinalsPharmaceuticalRitterUSA

US pharma and device firms paid doctors/hospitals ~$3.5 billion, CMS data show

US pharma and device firms paid doctors/hospitals ~$3.5 billion, CMS data show

01-10-2014

As part of its ongoing effort to increase transparency and accountability in health care, the Centers…

FinancialMedicare & Medicaid ServicesPharmaceuticalResearchUSA

ESMO 2014: Eisai’s lenvatinib could revolutionize treatment of rare thyroid cancer

ESMO 2014: Eisai’s lenvatinib could revolutionize treatment of rare thyroid cancer

30-09-2014

An orphan drug could offer real hope to patients with rare thyroid cancer, Japanese drugmaker Eisai revealed…

EisaiInterviewsJapanlenvatinibOncologyPharmaceuticalResearch

Johnson & Johnson to acquire Alios BioPharma

Johnson & Johnson to acquire Alios BioPharma

30-09-2014

US health care giant Johnson & Johnson has signed a definitive agreement to acquire Alios BioPharma,…

AL-8176Alios BioPharmaAnti-viralsJohnson & JohnsonMergers & AcquisitionsPharmaceuticalUSA

151 to 175 of 7083 results

Back to top